International Development Grant
Equitable access to therapeutics
Project Number: CA-3-P009897001
Status: Terminating
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $230,000,000.00
Start Date: March 30, 2021
End Date: December 31, 2024
Duration: 3.8 years
Project Description
This project supports the Access to COVID-19 Tools Accelerator (ACT-A). It aims to help ensure equitable access to COVID-19 therapeutics including novel antivirals and medical oxygen in Low-Income Countries (LICs) and Lower-Middle Income Countries (LMICs). Project activities include: (1) coordinating the procurement and delivery of COVID-19 antivirals; and (2) coordinating the procurement delivery and installation of medical oxygen facilities and supplies.
Expected Results
The expected outcomes of this project include: (1) increased equitable procurement and delivery of COVID-19 therapeutics; and (2) increased access to medical oxygen facilities and supplies.
Progress & Results Achieved
The result achieved as of December 2023 through the support of the Canadian government and other international donors includes the provision of novel COVID-19 antivirals medical oxygen facilities and supplies to 74 countries.
Key Information
Executing Agency:
UNICEF - United Nations Children's Fund
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Contributions to specific-purpose programmes and funds managed by implementing partners
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Department-Initiated